Organigram Holdings Inc. (TSE:OGI) Senior Officer Paolo De Luca Sells 12,014 Shares of Stock

Organigram Holdings Inc. (TSE:OGI) Senior Officer Paolo De Luca sold 12,014 shares of the stock in a transaction that occurred on Thursday, October 24th. The stock was sold at an average price of C$2.52, for a total transaction of C$30,275.28.

Paolo De Luca also recently made the following trade(s):

• On Wednesday, September 11th, Paolo De Luca sold 13,835 shares of Organigram stock. The stock was sold at an average price of C$2.54, for a total value of C$35,140.90.
• On Friday, August 16th, Paolo De Luca sold 10,266 shares of Organigram stock. The shares were sold at an average price of C$2.76, for a total value of C$28,334.16.

Organigram Stock Performance

TSE:OGI opened at C$2.55 on Wednesday. The firm’s fifty day simple moving average is C$2.47 and its 200 day simple moving average is C$2.40. The company has a current ratio of 6.95, a quick ratio of 2.62 and a debt-to-equity ratio of 1.13. Organigram Holdings Inc. has a twelve month low of C$1.36 and a twelve month high of C$3.95. The firm has a market capitalization of C$276.85 million, a price-to-earnings ratio of -1.02, a PEG ratio of 0.42 and a beta of 1.13.

Organigram (TSE:OGI) last issued its quarterly earnings data on Tuesday, August 13th. The company reported C$0.03 EPS for the quarter, topping analysts’ consensus estimates of C($0.07) by C$0.10. Organigram had a negative return on equity of 54.53% and a negative net margin of 153.80%. The company had revenue of C$41.06 million for the quarter, compared to analysts’ expectations of C$39.20 million. As a group, equities research analysts expect that Organigram Holdings Inc. will post 0.1632373 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group raised their price objective on Organigram from C$3.25 to C$3.60 and gave the stock a “speculative buy” rating in a report on Wednesday, August 14th.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.